Multifocal Electroretinography Before and After Silicone Oil Removal
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Minya, Egypt, 61111
- Recruiting
- Minia University Hospital
-
Contact:
- Mohamed A Hamid, MD
- Phone Number: +201024289366
- Email: drmohamedhamid83@mu.edu.eg
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients 18 years of age or older who underwent pars plana vitrectomy for the repair of rhegmatogenous retinal detachment (RRD) and received silicone oil as an intraocular tamponade.
Exclusion Criteria:
- Patients will be excluded if they have a significant corneal opacity, uncontrolled intraocular pressure, a confounding macular pathology or optic nerve pathology or if silicone oil has been in the eye for longer than 6 months.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Silicone-filled eyes
|
A device that records electric potentials generated by the retinal photoreceptors and neural elements in a multifocal fashion
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Amplitude
Time Frame: Preoperative and 1 month postoperative recordings
|
Change in amplitudes of P1 and N1 waves before and after silicone oil removal
|
Preoperative and 1 month postoperative recordings
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 34:3/2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Silicone Oil Filled Eyes
-
NCT02425085UnknownRetinal Redetachment in Silicone Oil-filled Eyes
-
NCT07418606Active, not recruitingCorneal Endothelial Cell Changes in Silicone Filled Eye
-
NCT06198738Not yet recruitingEmulsification of Silicone Oil in Eye Following Surgical Procedure
-
NCT05599854Not yet recruitingASOCT Changes After Vitrectomy and Silicone Oil Injection
-
NCT05647928CompletedRetinal Redetachment After Silicone Oil Removal
-
NCT04774146RecruitingRetinal Detachment | PArs Plana Vitrectomy | Silicone Oil Droplets on Intraocular Lens
-
NCT01255306CompletedRhegmatogenous Retinal Detachment | Toxic Effect of Silicone | Glaucoma Due to Silicon Oil
Clinical Trials on Multifocal electroretinogram
-
NCT05323032RecruitingRetinal Disease | Healthy Population
-
NCT05993208Completed
-
NCT03818971CompletedAlcohol Use Disorder
-
NCT02719002Completed
-
NCT00016471CompletedRetinitis Pigmentosa | Usher Syndrome | Congenital Hearing Impairment
-
NCT06782997Recruiting
-
NCT03422016CompletedAutism Spectrum Disorder